{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:39:15Z","timestamp":1792067955823,"version":"4.4.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NYU Center for Drug Use and HIV\/HCV Research","award":["CDUHR - P30 DA011041"],"award-info":[{"award-number":["CDUHR - P30 DA011041"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["3RO1DA046653-04S1"],"award-info":[{"award-number":["3RO1DA046653-04S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046653"],"award-info":[{"award-number":["R01DA046653"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Opioid withdrawal is a regular occurrence among many people who use illicit opioids (PWUIO) that has also been shown to increase their willingness to engage in risk-involved behavior. The proliferation of fentanyl in the illicit opioid market may have amplified this relationship, potentially putting PWUIO at greater risk of negative health outcomes. Understanding the relationship between withdrawal and risk-involved behavior may also have important implications for the ways that problematic drug use is conceptualized, particularly in disease models of addiction, which position risk behavior as evidence of pathology that helps to justify ontological distinctions between addicts and non-addicts. Examining withdrawal, and its role in PWUIO\u2019s willingness to engage in risk, may aid in the development of alternative theories of risk involvement and create discursive spaces for de-medicalizing and de-othering people who use illegal drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This article is based on 32 semi-structured interviews with PWUIO in the New York City area who also reported recent withdrawal experience. Interviews were conducted remotely between April and August 2022 and recorded for later transcription. Data were then coded and analyzed based on a combination of inductive and deductive coding strategies and informed by the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants described a strong relationship between withdrawal and their willingness to engage in risk-involved behavior that was exacerbated by the proliferation of fentanyl. Yet, their descriptions did not align with narratives of risk as a product of bad decisions made by individuals. Rather, data demonstrated the substantial role of social and structural context, particularly drug policies like prohibition and criminalization, in the kinds of risks that PWUIO faced and their ability to respond to them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Withdrawal should be taken more seriously both from an ethical perspective and as an important catalyst of risk behavior. However, theories that position activities taken to avoid withdrawal as irrational and as evidence of pathology are poorly aligned with the complexity of PWUIO\u2019s actual lives. We recommend the use of less deterministic and less medicalized theories of risk that better account for differences between how people view the world, and for the role of socio-structural forces in the production of risk.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12954-023-00893-9","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:01:50Z","timestamp":1698400910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["\u201cAs safe as possible\u201d: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids"],"prefix":"10.1186","volume":"20","author":[{"given":"David","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luther","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan M.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Joudrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Meyerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex S.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"893_CR1","doi-asserted-by":"publisher","first-page":"107932","DOI":"10.1016\/j.drugalcdep.2020.107932","volume":"211","author":"RN Bluthenthal","year":"2020","unstructured":"Bluthenthal RN, Simpson K, Ceasar RC, Zhao J, Wenger L, Kral AH. Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs. Drug Alcohol Depend. 2020;211:107932.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"893_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.drugpo.2009.08.007","volume":"21","author":"P Mateu-Gelabert","year":"2010","unstructured":"Mateu-Gelabert P, Sandoval M, Meylakhs P, Wendel T, Friedman SR. Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int J Drug Policy. 2010;21(3):179\u201385.","journal-title":"Int J Drug Policy"},{"key":"893_CR3","volume-title":"Opioid withdrawal. StatPearls [internet]","author":"M Shah","year":"2020","unstructured":"Shah M, Huecker MR. Opioid withdrawal. StatPearls [internet]. Treasure Island: StatPearls Publishing; 2020."},{"issue":"1\u20133","key":"893_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.drugalcdep.2008.07.007","volume":"99","author":"L Michel","year":"2009","unstructured":"Michel L, Giorgi R, Villes V, Poizot-Martin I, Dellamonica P, Spire B, et al. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART). Drug Alcohol Depend. 2009;99(1\u20133):96\u2013104.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"893_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/16066359.2015.1068301","volume":"24","author":"KT Phillips","year":"2016","unstructured":"Phillips KT. Barriers to practicing risk reduction strategies among people who inject drugs. Addict Res Theory. 2016;24(1):62\u20138.","journal-title":"Addict Res Theory"},{"issue":"7","key":"893_CR6","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/add.12151","volume":"108","author":"T Kerr","year":"2013","unstructured":"Kerr T, Small W, Hyshka E, Maher L, Shannon K. \u2018It\u2019s more about the heroin\u2019: injection drug users\u2019 response to an overdose warning campaign in a Canadian setting. Addiction. 2013;108(7):1270\u20136.","journal-title":"Addiction"},{"issue":"1","key":"893_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1525\/maq.1994.8.1.02a00040","volume":"8","author":"MM Connors","year":"1992","unstructured":"Connors MM, WHR Rivers Prize Essay. Stories of Pain and the Problem of AIDS Prevention: Injection Drug Withdrawal and Its Effect on Risk Behavior. Med Anthropol Q. 1992;8(1):47\u201368.","journal-title":"Med Anthropol Q"},{"key":"893_CR8","unstructured":"Grey E. As an es-heroin addict, I know getting of opioids is near impossible. Washington Post. 2022."},{"key":"893_CR9","doi-asserted-by":"publisher","first-page":"103348","DOI":"10.1016\/j.drugpo.2021.103348","volume":"98","author":"D Frank","year":"2021","unstructured":"Frank D. \u201cI\u2019m pretty sure it\u2019s either food poisoning or Covid-19\u201d: lived experience versus medical knowledge in diagnosing substance use problems. Int J Drug Policy. 2021;98:103348.","journal-title":"Int J Drug Policy"},{"key":"893_CR10","unstructured":"Siegel Z. The fentanyl withdrawal from hell. Substance. 2023."},{"key":"893_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107\u201311.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"893_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344.","journal-title":"Curr Opin Psychiatry"},{"key":"893_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"893_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/ajad.13092","volume":"30","author":"S Martinez","year":"2021","unstructured":"Martinez S, Jones JD, Brandt L, Campbell AN, Abbott R, Comer SD. The increasing prevalence of fentanyl: a urinalysis-based study among individuals with opioid use disorder in New York City. Am J Addict. 2021;30(1):65\u201371.","journal-title":"Am J Addict"},{"issue":"5","key":"893_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/EDE.0000000000000858","volume":"29","author":"MJ Alexander","year":"2018","unstructured":"Alexander MJ, Kiang MV, Barbieri M. Trends in black and white opioid mortality in the United States, 1979\u20132015. Epidemiology. 2018;29(5):707.","journal-title":"Epidemiology"},{"issue":"4","key":"893_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/PAF.0000000000000787","volume":"43","author":"DM Papsun","year":"2022","unstructured":"Papsun DM, Krotulski AJ, Logan BK. Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances. Am J Forensic Med Pathol. 2022;43(4):315\u201327.","journal-title":"Am J Forensic Med Pathol"},{"issue":"2","key":"893_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bph.14860","volume":"177","author":"R Hill","year":"2020","unstructured":"Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G. Fentanyl depression of respiration: comparison with heroin and morphine. Br J Pharmacol. 2020;177(2):254\u201365.","journal-title":"Br J Pharmacol"},{"key":"893_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","volume":"134","author":"P Armenian","year":"2018","unstructured":"Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology. 2018;134:121\u201332.","journal-title":"Neuropharmacology"},{"issue":"43","key":"893_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","volume":"66","author":"JK O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700\u201410 states, July\u2013December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"893_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.15585\/mmwr.mm6634a3","volume":"66","author":"R Daniulaityte","year":"2017","unstructured":"Daniulaityte R, Juhascik MP, Strayer KE, Sizemore IE, Harshbarger KE, Antonides HM, et al. Overdose deaths related to fentanyl and its analogs\u2014Ohio, January\u2013February 2017. MMWR Morb Mortal Wkly Rep. 2017;66(34):904.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"893_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1353\/ppp.0.0282","volume":"17","author":"B Foddy","year":"2010","unstructured":"Foddy B, Savulescu J. A liberal account of addiction. Philos Psychiatry Psychol. 2010;17(1):1.","journal-title":"Philos Psychiatry Psychol"},{"issue":"3\u20134","key":"893_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0952695120945962","volume":"34","author":"D Weinberg","year":"2021","unstructured":"Weinberg D. Freedom and addiction in four discursive registers: a comparative historical study of values in addiction science. Hist Hum Sci. 2021;34(3\u20134):25\u201348.","journal-title":"Hist Hum Sci"},{"key":"893_CR23","doi-asserted-by":"publisher","DOI":"10.1057\/9781137316776","volume-title":"Habits: remaking addiction","author":"S Fraser","year":"2014","unstructured":"Fraser S, Moore D, Keane H. Habits: remaking addiction. Berlin: Springer; 2014."},{"key":"893_CR24","volume-title":"What's wrong with addiction?","author":"H Keane","year":"2002","unstructured":"Keane H. What\u2019s wrong with addiction? Melbourne: Melbourne University Publish; 2002."},{"key":"893_CR25","unstructured":"Michaud M. Study sheds light on source of drug addicts risk-taking behavior. 2016."},{"key":"893_CR26","doi-asserted-by":"crossref","unstructured":"Kaye K. De-medicalizing addiction: Toward biocultural understandings. Critical perspectives on addiction. 2012.","DOI":"10.1108\/S1057-6290(2012)0000014006"},{"key":"893_CR27","doi-asserted-by":"publisher","DOI":"10.1108\/S1057-6290(2012)14","volume-title":"Introduction: sociology and the shifting landscape of addiction. Critical perspectives on addiction","author":"J Netherland","year":"2012","unstructured":"Netherland J. Introduction: sociology and the shifting landscape of addiction. Critical perspectives on addiction. Bingley: Emerald Group Publishing Limited; 2012."},{"key":"893_CR28","unstructured":"Sinha S, Lieberman Z, Dvis L. Heroin addiction explained: how opioids hijack the brain. 2018. p. https:\/\/www.nytimes.com\/interactive\/2018\/us\/addiction-heroin-opioids.html."},{"key":"893_CR29","doi-asserted-by":"crossref","DOI":"10.3998\/mpub.269246","volume-title":"Discovering addiction: the science and politics of substance abuse research","author":"ND Campbell","year":"2007","unstructured":"Campbell ND. Discovering addiction: the science and politics of substance abuse research. Ann Arbor: University of Michigan Press; 2007."},{"key":"893_CR30","doi-asserted-by":"crossref","unstructured":"Lupton D. Risk. Routledge; 2013.","DOI":"10.4324\/9780203070161"},{"issue":"5","key":"893_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1467-9566.2007.01018.x","volume":"29","author":"K Hughes","year":"2007","unstructured":"Hughes K. Migrating identities: the relational constitution of drug use and addiction. Sociol Health Illn. 2007;29(5):673\u201391.","journal-title":"Sociol Health Illn"},{"issue":"3","key":"893_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/09581599808402908","volume":"8","author":"GY Koutroulis","year":"1998","unstructured":"Koutroulis GY. Withdrawal from injecting heroin use: thematizing the body. Crit Public Health. 1998;8(3):207\u201324.","journal-title":"Crit Public Health"},{"issue":"4","key":"893_CR33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1086\/217773","volume":"43","author":"AR Lindesmith","year":"1938","unstructured":"Lindesmith AR. A sociological theory of drug addiction. Am J Sociol. 1938;43(4):593\u2013613.","journal-title":"Am J Sociol"},{"issue":"9737","key":"893_CR34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","volume":"376","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. The Lancet. 2010;376(9737):268\u201384.","journal-title":"The Lancet"},{"issue":"2","key":"893_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85\u201394.","journal-title":"Int J Drug Policy"},{"key":"893_CR36","first-page":"193","volume-title":"Risk environments and drug harms: a social science for harm reduction approach","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Amsterdam: Elsevier; 2009. p. 193\u2013201."},{"issue":"S1","key":"893_CR37","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.2105\/AJPH.2018.304844","volume":"109","author":"AF Brown","year":"2019","unstructured":"Brown AF, Ma GX, Miranda J, Eng E, Castille D, Brockie T, et al. Structural interventions to reduce and eliminate health disparities. Am J Public Health. 2019;109(S1):S72\u20138.","journal-title":"Am J Public Health"},{"key":"893_CR38","doi-asserted-by":"publisher","first-page":"112384","DOI":"10.1016\/j.socscimed.2019.112384","volume":"234","author":"AB Collins","year":"2019","unstructured":"Collins AB, Boyd J, Cooper HL, McNeil R. The intersectional risk environment of people who use drugs. Soc Sci Med. 2019;234:112384.","journal-title":"Soc Sci Med"},{"issue":"50\u201351","key":"893_CR39","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths: United States, 2000\u20132014. MMWR Morb Mortal Wkly Rep. 2016;64(50\u201351):1378\u201382.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"893_CR40","first-page":"e1","volume":"2021","author":"J Friedman","year":"2021","unstructured":"Friedman J, Akre S. COVID-19 and the drug overdose crisis: uncovering the deadliest months in the United States, January\u2013July 2020. Am J Public Health. 2021;2021:e1\u20138.","journal-title":"Am J Public Health"},{"key":"893_CR41","unstructured":"NIDA. Drug overdose death rates. 2023."},{"key":"893_CR42","doi-asserted-by":"crossref","unstructured":"Neumann CB, Neumann IB. Power, culture and situated research methodology: autobiography, field. Text [online text]. 2018.","DOI":"10.1007\/978-3-319-59217-6"},{"key":"893_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fsoc.2021.619677","volume":"6","author":"D Frank","year":"2021","unstructured":"Frank D, Walters SM. \u201cI\u2019m going to stop myself before someone stops me\u201d: complicating narratives of volitional substance use treatment. Front Sociol. 2021;6:6.","journal-title":"Front Sociol"},{"key":"893_CR44","doi-asserted-by":"publisher","DOI":"10.18584\/iipj.2018.9.2.3","author":"A Goodman","year":"2018","unstructured":"Goodman A, Morgan R, Kuehlke R, Kastor S, Fleming K, Boyd J. \u201cWe\u2019ve been researched to death\u201d: exploring the research experiences of urban Indigenous peoples in Vancouver, Canada. Int Indig Policy J. 2018. https:\/\/doi.org\/10.18584\/iipj.2018.9.2.3.","journal-title":"Int Indig Policy J"},{"key":"893_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.17269\/s41997-018-0167-x","volume":"110","author":"AM Greer","year":"2019","unstructured":"Greer AM, Amlani A, Burmeister C, Scott A, Newman C, Lampkin H, et al. Peer engagement barriers and enablers: insights from people who use drugs in British Columbia, Canada. Can J Public Health. 2019;110:227\u201335.","journal-title":"Can J Public Health"},{"key":"893_CR46","doi-asserted-by":"publisher","first-page":"103364","DOI":"10.1016\/j.drugpo.2021.103364","volume":"98","author":"C Simon","year":"2021","unstructured":"Simon C, Brothers S, Strichartz K, Coulter A, Voyles N, Herdlein A, et al. We are the researched, the researchers, and the discounted: the experiences of drug user activists as researchers. Int J Drug Policy. 2021;98:103364.","journal-title":"Int J Drug Policy"},{"key":"893_CR47","first-page":"S117","volume-title":"The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists","author":"C Simon","year":"2022","unstructured":"Simon C, Vincent L, Coulter A, Salazar Z, Voyles N, Roberts L, et al. The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists. Washington, D.C.: American Public Health Association; 2022. p. S117\u201322."},{"key":"893_CR48","doi-asserted-by":"publisher","first-page":"103112","DOI":"10.1016\/j.drugpo.2021.103112","volume":"93","author":"BE Meyerson","year":"2021","unstructured":"Meyerson BE, Russell DM, Kichler M, Atkin T, Fox G, Coles HB. I don\u2019t even want to go to the doctor when I get sick now: healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. Int J Drug Policy. 2021;93:103112.","journal-title":"Int J Drug Policy"},{"key":"893_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0327-1","volume":"16","author":"BE Meyerson","year":"2019","unstructured":"Meyerson BE, Lawrence CA, Cope SD, Levin S, Thomas C, Eldridge LA, et al. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018. Harm Reduct J. 2019;16:1\u20139.","journal-title":"Harm Reduct J"},{"issue":"10","key":"893_CR50","doi-asserted-by":"publisher","first-page":"e0274094","DOI":"10.1371\/journal.pone.0274094","volume":"17","author":"BE Meyerson","year":"2022","unstructured":"Meyerson BE, Bentele KG, Russell DM, Brady BR, Downer M, Garcia RC, et al. Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID. PLoS ONE. 2022;17(10):e0274094.","journal-title":"PLoS ONE"},{"issue":"CSCW","key":"893_CR51","first-page":"1","volume":"3","author":"N McDonald","year":"2019","unstructured":"McDonald N, Schoenebeck S, Forte A. Reliability and inter-rater reliability in qualitative research: norms and guidelines for CSCW and HCI practice. Proc ACM Hum Comput Interact. 2019;3(CSCW):1\u201323.","journal-title":"Proc ACM Hum Comput Interact"},{"key":"893_CR52","unstructured":"McAlister AM, Lee DM, Ehlert KM, Kajfez RL, Faber CJ, Kennedy MS, editors. Qualitative coding: an approach to assess inter-rater reliability. In: 2017 ASEE annual conference & exposition; 2017."},{"issue":"3","key":"893_CR53","first-page":"3351","volume":"9","author":"M Maguire","year":"2017","unstructured":"Maguire M, Delahunt B. Doing a thematic analysis: a practical, step-by-step guide for learning and teaching scholars. All Irel J High Educ. 2017;9(3):3351.","journal-title":"All Irel J High Educ"},{"key":"893_CR54","doi-asserted-by":"publisher","DOI":"10.5430\/jnep.v6n5p100","author":"M Vaismoradi","year":"2016","unstructured":"Vaismoradi M, Jones J, Turunen H, Snelgrove S. Theme development in qualitative content analysis and thematic analysis. J Nurs Educ Pract. 2016. https:\/\/doi.org\/10.5430\/jnep.v6n5p100.","journal-title":"J Nurs Educ Pract"},{"key":"893_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","volume":"46","author":"L Beletsky","year":"2017","unstructured":"Beletsky L, Davis CS. Today\u2019s fentanyl crisis: prohibition\u2019s iron law, revisited. Int J Drug Policy. 2017;46:156\u20139.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"893_CR56","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/add.14474","volume":"114","author":"SG Mars","year":"2019","unstructured":"Mars SG, Rosenblum D, Ciccarone D. Illicit fentanyls in the opioid street market: desired or imposed? Addiction. 2019;114(5):774\u201380.","journal-title":"Addiction"},{"issue":"2","key":"893_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","volume":"25","author":"SG Mars","year":"2014","unstructured":"Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. \u201cEvery \u2018never\u2019I ever said came true\u201d: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257\u201366.","journal-title":"Int J Drug Policy"},{"key":"893_CR58","doi-asserted-by":"publisher","DOI":"10.4324\/9780203107928","volume-title":"Ulrich beck: an introduction to the theory of second modernity and the risk society","author":"M S\u00f8rensen","year":"2012","unstructured":"S\u00f8rensen M, Christiansen A. Ulrich beck: an introduction to the theory of second modernity and the risk society. London: Routledge; 2012."},{"key":"893_CR59","volume-title":"World at risk","author":"U Beck","year":"2009","unstructured":"Beck U. World at risk. Cambridge: Polity; 2009."},{"key":"893_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1468-2230.00188","volume":"62","author":"A Giddens","year":"1999","unstructured":"Giddens A. Risk and responsibility. Mod Law Rev. 1999;62:1.","journal-title":"Mod Law Rev"},{"key":"893_CR61","first-page":"37","volume-title":"Fate, risk and security. The sociology of risk and gambling reader","author":"A Giddens","year":"2006","unstructured":"Giddens A. Fate, risk and security. The sociology of risk and gambling reader. London: Routledge; 2006. p. 37\u201367."},{"key":"893_CR62","volume-title":"High price: drugs, neuroscience, and discovering myself","author":"C Hart","year":"2013","unstructured":"Hart C. High price: drugs, neuroscience, and discovering myself. London: Penguin; 2013."},{"issue":"2","key":"893_CR63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","volume":"108","author":"N Dasgupta","year":"2018","unstructured":"Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182\u20136.","journal-title":"Am J Public Health"},{"issue":"2","key":"893_CR64","first-page":"35","volume":"34","author":"L Beletsky","year":"2019","unstructured":"Beletsky L, Goulka J. The opioid crisis. Crim Justice. 2019;34(2):35\u201340.","journal-title":"Crim Justice"},{"key":"893_CR65","volume-title":"Discipline and punish: the birth of the prison","author":"M Foucault","year":"2012","unstructured":"Foucault M. Discipline and punish: the birth of the prison. New York: Vintage; 2012."},{"key":"893_CR66","doi-asserted-by":"publisher","DOI":"10.4324\/9780203164693","volume-title":"Madness and civilization","author":"M Foucault","year":"2003","unstructured":"Foucault M. Madness and civilization. London: Routledge; 2003."},{"key":"893_CR67","volume-title":"Righteous dopefiend","author":"P Bourgois","year":"2009","unstructured":"Bourgois P, Bourgois PI, Schonberg J. Righteous dopefiend. Berkeley: University of California Press; 2009."},{"key":"893_CR68","volume-title":"Of others inside: Insanity, addiction, and belonging in America","author":"D Weinberg","year":"2005","unstructured":"Weinberg D. Of others inside: Insanity, addiction, and belonging in America. Philadelphia: Temple University Press; 2005."},{"issue":"11","key":"893_CR69","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3109\/10826089809056260","volume":"33","author":"P Bourgois","year":"1998","unstructured":"Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Subst Use Misuse. 1998;33(11):2323\u201351.","journal-title":"Subst Use Misuse"},{"key":"893_CR70","doi-asserted-by":"publisher","DOI":"10.4324\/9780429424311","volume-title":"The logic of violence: an ethnography of Dublin's illegal drug trade","author":"B Marsh","year":"2019","unstructured":"Marsh B. The logic of violence: an ethnography of Dublin\u2019s illegal drug trade. London: Routledge; 2019."},{"issue":"3","key":"893_CR71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10612-015-9312-5","volume":"24","author":"S Wakeman","year":"2016","unstructured":"Wakeman S. The moral economy of heroin in \u2018Austerity Britain.\u2019 Crit Criminol. 2016;24(3):363\u201377.","journal-title":"Crit Criminol"},{"key":"893_CR72","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511520778","volume-title":"Risk and sociocultural theory: new directions and perspectives","author":"D Lupton","year":"1999","unstructured":"Lupton D. Risk and sociocultural theory: new directions and perspectives. Cambridge: Cambridge University Press; 1999."},{"issue":"3","key":"893_CR73","doi-asserted-by":"publisher","first-page":"e0230408","DOI":"10.1371\/journal.pone.0230408","volume":"15","author":"E Behar","year":"2020","unstructured":"Behar E, Bagnulo R, Knight K, Santos G-M, Coffin PO. \u201cChasing the pain relief, not the high\u201d: experiences managing pain after opioid reductions among patients with HIV and a history of substance use. PLoS ONE. 2020;15(3):e0230408.","journal-title":"PLoS ONE"},{"key":"893_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0241-y","volume":"15","author":"P Voon","year":"2018","unstructured":"Voon P, Greer AM, Amlani A, Newman C, Burmeister C, Buxton JA. Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm Reduct J. 2018;15:1\u20139.","journal-title":"Harm Reduct J"},{"key":"893_CR75","doi-asserted-by":"publisher","first-page":"112734","DOI":"10.1016\/j.socscimed.2019.112734","volume":"246","author":"L Dassieu","year":"2020","unstructured":"Dassieu L, Kabor\u00e9 J-L, Choini\u00e8re M, Arruda N, Roy \u00c9. Painful lives: Chronic pain experience among people who use illicit drugs in Montreal (Canada). Soc Sci Med. 2020;246:112734.","journal-title":"Soc Sci Med"},{"issue":"2","key":"893_CR76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1155\/2015\/868746","volume":"20","author":"L Ti","year":"2015","unstructured":"Ti L, Voon P, Dobrer S, Montaner J, Wood E, Kerr T. Denial of pain medication by health care providers predicts in-hospital illicit drug use among individuals who use illicit drugs. Pain Res Manag. 2015;20(2):84\u20138.","journal-title":"Pain Res Manag"},{"issue":"2","key":"893_CR77","doi-asserted-by":"publisher","first-page":"463","DOI":"10.4103\/2249-4863.192376","volume":"5","author":"S Oberoi","year":"2016","unstructured":"Oberoi S, Chaudhary N, Patnaik S, Singh A. Understanding health seeking behavior. J Fam Med Prim Care. 2016;5(2):463.","journal-title":"J Fam Med Prim Care"},{"issue":"6","key":"893_CR78","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0306-4603(96)00042-1","volume":"21","author":"GA Marlatt","year":"1996","unstructured":"Marlatt GA. Harm reduction: come as you are. Addict Behav. 1996;21(6):779\u201388.","journal-title":"Addict Behav"},{"key":"893_CR79","volume-title":"Harm reduction is a social movement","author":"J Solanki","year":"2019","unstructured":"Solanki J. Harm reduction is a social movement. Waterloo: University of Waterloo; 2019."},{"issue":"2","key":"893_CR80","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/09581596.2011.611487","volume":"22","author":"CB Smith","year":"2012","unstructured":"Smith CB. Harm reduction as anarchist practice: a user\u2019s guide to capitalism and addiction in North America. Crit Public Health. 2012;22(2):209\u201321.","journal-title":"Crit Public Health"},{"issue":"4","key":"893_CR81","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/0091450916666641","volume":"43","author":"I Walmsley","year":"2016","unstructured":"Walmsley I. Coming off drugs: a critical history of the withdrawing body. Contemp Drug Probl. 2016;43(4):381\u201396.","journal-title":"Contemp Drug Probl"},{"issue":"2","key":"893_CR82","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10826084.2017.1310247","volume":"53","author":"D Frank","year":"2018","unstructured":"Frank D. \u201cI was not sick and I didn\u2019t need to recover\u201d: Methadone Maintenance Treatment (MMT) as a refuge from criminalization. Subst Use Misuse. 2018;53(2):311\u201322.","journal-title":"Subst Use Misuse"},{"key":"893_CR83","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.drugpo.2020.102844","volume":"83","author":"D Frank","year":"2020","unstructured":"Frank D. Methadone maintenance treatment is swapping one drug for another, and that\u2019s why it works: towards a treatment-based critique of the war on drugs. Int J Drug Policy. 2020;83:102844.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"893_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-021-00535-y","volume":"18","author":"D Frank","year":"2021","unstructured":"Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. \u201cIt\u2019s like \u2018liquid handcuffs\u201d: the effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients\u2019 lives. Harm Reduct J. 2021;18(1):1\u201310.","journal-title":"Harm Reduct J"},{"key":"893_CR85","unstructured":"Coulter A, editor. Highlighting the lived experience of MMT patients. Methadone treatment for opioid use disorder: examining federal regulations and laws a workshop; 2022."},{"key":"893_CR86","unstructured":"Dooling BaS, Laura. A vast and discretionary regime: federal regulation of methadone as a treatment for opioid use disorder. 2022."},{"key":"893_CR87","volume-title":"The methadone manifesto","author":"USU","year":"2021","unstructured":"USU. The methadone manifesto. Greensboro: Urban Survivors Union; 2021."},{"issue":"1","key":"893_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0376-8716(96)01230-6","volume":"41","author":"M Torrens","year":"1996","unstructured":"Torrens M, Castillo C, P\u00e9rez-Sol\u00e1 V. Retention in a low-threshold methadone maintenance program. Drug Alcohol Depend. 1996;41(1):55\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"893_CR89","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.drugpo.2013.05.005","volume":"24","author":"C Strike","year":"2013","unstructured":"Strike C, Millson M, Hopkins S, Smith C. What is low threshold methadone maintenance treatment? Int J Drug Policy. 2013;24(6):e51\u20136.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"893_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-020-00186-7","volume":"15","author":"A Scheibe","year":"2020","unstructured":"Scheibe A, Shelly S, Gerardy T, Von Homeyer Z, Schneider A, Padayachee K, et al. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addict Sci Clin Pract. 2020;15(1):1\u201311.","journal-title":"Addict Sci Clin Pract"},{"key":"893_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2015.08.037","volume":"156","author":"S Nolan","year":"2015","unstructured":"Nolan S, Hayashi K, Milloy M-J, Kerr T, Dong H, Lima VD, et al. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting. Drug Alcohol Depend. 2015;156:57\u201361.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"893_CR92","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1521\/aeap.2007.19.2.124","volume":"19","author":"P Millson","year":"2007","unstructured":"Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, et al. Reduction in injection\u2013related hiv risk after 6 months in a low-threshold methadone treatment program. AIDS Educ Prev. 2007;19(2):124\u201336.","journal-title":"AIDS Educ Prev"},{"issue":"32","key":"893_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adaw.33525","volume":"34","author":"A Knopf","year":"2022","unstructured":"Knopf A. Do patients addicted to fentanyl need higher doses of methadone or buprenorphine? Alcohol Drug Abuse Wkly. 2022;34(32):1\u20137.","journal-title":"Alcohol Drug Abuse Wkly"},{"issue":"2","key":"893_CR94","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/dar.13394","volume":"41","author":"D Shearer","year":"2022","unstructured":"Shearer D, Young S, Fairbairn N, Brar R. Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: a case series. Drug Alcohol Rev. 2022;41(2):444\u20138.","journal-title":"Drug Alcohol Rev"},{"key":"893_CR95","unstructured":"Bromley L, Kahan M, Regenstreif L, Srivastava A, Wyman J, Dabam F. Methadone treatment for people who use fentanyl: recommendations. Tor METAPHI Published online. 2021;30."},{"issue":"8","key":"893_CR96","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa0810635","volume":"361","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009;361(8):777\u201386.","journal-title":"N Engl J Med"},{"key":"893_CR97","doi-asserted-by":"publisher","first-page":"102769","DOI":"10.1016\/j.drugpo.2020.102769","volume":"80","author":"A Ivsins","year":"2020","unstructured":"Ivsins A, Boyd J, Beletsky L, McNeil R. Tackling the overdose crisis: the role of safe supply. Int J Drug Policy. 2020;80:102769.","journal-title":"Int J Drug Policy"},{"key":"893_CR98","first-page":"547","volume":"42","author":"C Minhee","year":"2019","unstructured":"Minhee C, Calandrillo S. The cure for America\u2019s opioid crisis: end the war on drugs. Harv JL Pub Pol\u2019y. 2019;42:547.","journal-title":"Harv JL Pub Pol'y"},{"key":"893_CR99","first-page":"787","volume":"80","author":"J Bowers","year":"2019","unstructured":"Bowers J, Abrahamson D. Kicking the habit: the opioid crisis, America\u2019s addiction to punitive prohibition, and the promise of free heroin. Ohio St LJ. 2019;80:787.","journal-title":"Ohio St LJ"},{"issue":"1","key":"893_CR100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1477370819887514","volume":"19","author":"A Stevens","year":"2022","unstructured":"Stevens A, Hughes CE, Hulme S, Cassidy R. Depenalization, diversion and decriminalization: a realist review and programme theory of alternatives to criminalization for simple drug possession. Eur J Criminol. 2022;19(1):29\u201354.","journal-title":"Eur J Criminol"},{"key":"893_CR101","volume-title":"Drug use for grown-ups: chasing liberty in the land of fear","author":"CL Hart","year":"2022","unstructured":"Hart CL. Drug use for grown-ups: chasing liberty in the land of fear. New York: Penguin; 2022."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00893-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T22:47:10Z","timestamp":1730414830000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00893-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00893-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"24 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent and are referred to by pseudonyms, and the study was approved by the New York University Langone Institutional Review Board. The authors report no conflicts of interest. The author alone is responsible for the content and writing of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This article contains no identifiable information from participants. All co-authors have consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}